Intellia Therapeutics
Biotech · 7 tracked clinical trials
Clinical Pipeline
| Trial | Phase | Status | Indication |
|---|---|---|---|
| NCT06128629 | PHASE3 | RECRUITING | Transthyretin Amyloidosis (ATTR) With Cardiomyopathy |
| NCT06672237 | PHASE3 | RECRUITING | Neuromuscular Disease, Neuromuscular Diseases (NMD), Neurodegenerative Disease |
| NCT06634420 | PHASE3 | ACTIVE_NOT_RECRUITING | Hereditary Angioedema |
| NCT06379789 | PHASE1, PHASE2 | RECRUITING | Hemophilia B |
| NCT05120830 | PHASE1, PHASE2 | ACTIVE_NOT_RECRUITING | Hereditary Angioedema |
| NCT06262399 | — | ENROLLING_BY_INVITATION | Hereditary Angioedema |
| NCT05697861 | — | RECRUITING | Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy, Wild-Type Transthyretin Cardiac Amyloidosis |